Prosecution Insights
Last updated: August 17, 2026

The Feinstein Institutes for Medical Research

14 pending office actions • 8 art units • 14 examiners • 0 of 14 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
11
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
4
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (50%)
7
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (7%)
§103 only6 (43%)
§102 only1 (7%)
Multi-statute (no §101)6 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
29% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
8
Mechanical / Eng
57% of docket
2
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HARVEY, JULIANNA NANCY 1 77.9% +19.0%
TRAN, THIEN JASON 1 74.1% +24.2%
EDWARDS, PHILIP CHARLES 1 85.4% +14.8%
COTRONEO, STEVEN J 1 69.2% +32.1%
NGUYEN, HIEN NGOC 1 52.7% +40.2%
KUO, JONATHAN T 1 72.5% +27.7%
SANCHEZ, JUSTIN CHRISTOPHER 1 86.4% +14.7%
SKROBARCZYK III, ROBERT ANTHONY 1 12.5% +25.6%
CARTER, TARA ROSE E 1 80.6% +9.7%
BERKE-SCHLESSEL, DAVID W 1 66.6% +31.9%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19002650 METHODS AND APPARATUSES FOR REDUCING BLEEDING VIA COORDINATED TRIGEMINAL AND VAGAL NERVE STIMULATION EDWARDS, PHILIP CHARLES
18706490 LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST SANCHEZ, JUSTIN CHRISTOPHER

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18278688 NEURAL CONTROL OF ADAPTIVE IMMUNITY ANTHOPOLOS, PETER 14d
18229495 AUTOMATED CARDIOPULMONARY RESUSCITATION DEVICE MILLER, CHRISTOPHER E 14d
18583007 ADAPTER FOR SURGICAL RETRACTOR POSITIONING DEVICE CARTER, TARA ROSE E 27d
18905283 A SYSTEM AND A METHOD FOR CONTROLLING SELECTIVE NERVE STIMULATION OF NEURAL TISSUE OF A SUBJECT TRAN, THIEN JASON
18645129 SYSTEMS AND METHODS OF STIMULATION AT TRIGEMINALLY INNERVATED REGIONS FOR DISORDERS OF CEREBRAL PERFUSION SKROBARCZYK III, ROBERT ANTHONY
18538023 Chimeric molecule to treat sepsis and other inflammatory conditions VARADARAJ, ARCHANA
18120714 METHODS FOR DETECTING AND TREATING PROGESTERONE-RESISTANT INFERTILITY JOHANNSEN, DIANA B

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18771579 SYSTEM AND METHOD FOR NEURAL TISSUE ANATOMY ESTIMATION AND SELECTIVE NEURAL STIMULATION KUO, JONATHAN T 19d
19262375 EAR SPECULUM WITH FLUID DELIVERY DEVICE HARVEY, JULIANNA NANCY
18905283 A SYSTEM AND A METHOD FOR CONTROLLING SELECTIVE NERVE STIMULATION OF NEURAL TISSUE OF A SUBJECT TRAN, THIEN JASON
19002650 METHODS AND APPARATUSES FOR REDUCING BLEEDING VIA COORDINATED TRIGEMINAL AND VAGAL NERVE STIMULATION EDWARDS, PHILIP CHARLES
18964145 EXPANDABLE INTERVERTEBRAL SPACER COTRONEO, STEVEN J
18929926 STIMULATION OF THE CELIAC-SUPERIOR MESENTERIC GANGLION COMPLEX FOR TREATING INFLAMMATION NGUYEN, HIEN NGOC
18706490 LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST SANCHEZ, JUSTIN CHRISTOPHER
18645129 SYSTEMS AND METHODS OF STIMULATION AT TRIGEMINALLY INNERVATED REGIONS FOR DISORDERS OF CEREBRAL PERFUSION SKROBARCZYK III, ROBERT ANTHONY

Top Art Units

Art UnitApps
3773 3
3792 3
3797 1
1651 1
1658 1
1611 1
3785 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19262375 EAR SPECULUM WITH FLUID DELIVERY DEVICE HARVEY, JULIANNA NANCY 3773 §103 Non-Final OA Pending Jul 08, 2025
18905283 A SYSTEM AND A METHOD FOR CONTROLLING SELECTIVE NERVE STIMULATION OF NEURAL TISSUE OF A SUBJECT TRAN, THIEN JASON 3792 §102§103 Non-Final OA Pending Oct 03, 2024
19002650 METHODS AND APPARATUSES FOR REDUCING BLEEDING VIA COORDINATED TRIGEMINAL AND VAGAL NERVE STIMULATION EDWARDS, PHILIP CHARLES §103 Non-Final OA Pending Dec 26, 2024
18964145 EXPANDABLE INTERVERTEBRAL SPACER COTRONEO, STEVEN J 3773 §102 Non-Final OA Pending Nov 29, 2024
18929926 STIMULATION OF THE CELIAC-SUPERIOR MESENTERIC GANGLION COMPLEX FOR TREATING INFLAMMATION NGUYEN, HIEN NGOC 3797 §103 Non-Final OA Pending Oct 29, 2024
18771579 SYSTEM AND METHOD FOR NEURAL TISSUE ANATOMY ESTIMATION AND SELECTIVE NEURAL STIMULATION KUO, JONATHAN T 3792 §103 Final Rejection 19d Pending Jul 12, 2024
18706490 LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST SANCHEZ, JUSTIN CHRISTOPHER §103 Non-Final OA Pending May 01, 2024
18645129 SYSTEMS AND METHODS OF STIMULATION AT TRIGEMINALLY INNERVATED REGIONS FOR DISORDERS OF CEREBRAL PERFUSION SKROBARCZYK III, ROBERT ANTHONY 3792 §103§112 Non-Final OA Pending Apr 24, 2024
18583007 ADAPTER FOR SURGICAL RETRACTOR POSITIONING DEVICE CARTER, TARA ROSE E 3773 §102§112Other Non-Final OA 27d Pending Feb 21, 2024
18293972 CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES BERKE-SCHLESSEL, DAVID W 1651 §103 Non-Final OA Pending Jan 31, 2024
18538023 Chimeric molecule to treat sepsis and other inflammatory conditions VARADARAJ, ARCHANA 1658 §102§103 Non-Final OA Pending Dec 13, 2023
18278688 NEURAL CONTROL OF ADAPTIVE IMMUNITY ANTHOPOLOS, PETER 1611 §102§112 Final Rejection 14d Pending Aug 24, 2023
18229495 AUTOMATED CARDIOPULMONARY RESUSCITATION DEVICE MILLER, CHRISTOPHER E 3785 §101§102§103§112 Non-Final OA 14d Pending Aug 02, 2023
18120714 METHODS FOR DETECTING AND TREATING PROGESTERONE-RESISTANT INFERTILITY JOHANNSEN, DIANA B 1682 §102§103§112 Final Rejection Pending Mar 13, 2023

Managing The Feinstein Institutes for Medical Research's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month